CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547851
- Phone
- (858) 500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $1,239,000
- in 1 filing
- Open-market sales, last 90 days
- $1,708,041
- in 8 filings, $650K under 10b5-1 plans
Net −$469,041. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$1.2M President and CEO 1 filing
- Bair Teresa Brophy −$486K Chief Legal Officer sold 18% of stake
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-24 | Burrows Francis Chief Scientific Officer | Option exercise | +30,000 | $6.15 | $185K | 63,053 |
| 2026-09-24 | Burrows Francis Chief Scientific Officer | Sale | −20,726 | $10.83 | $225K | 42,327 |
| 2026-09-24 | Burrows Francis Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −30,000 | 0 | ||
| 2026-01-27 | Burrows Francis Chief Scientific Officer | Sale | −1,311 | $8.46 | $11K | 32,424 |
| 2026-01-02 | Burrows Francis Chief Scientific Officer | Grant or award · Option to purchase common stock | +185,000 | 185,000 | ||
| 2025-12-18 | Burrows Francis Chief Scientific Officer | Option exercise | +35,000 | $4.80 | $168K | 57,461 |
| 2025-12-18 | Burrows Francis Chief Scientific Officer | Sale | −23,726 | $9.78 | $232K | 33,735 |
| 2025-12-18 | Burrows Francis Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −35,000 | 0 | ||
| 2025-01-28 | Burrows Francis Chief Scientific Officer | Sale | −846 | $7.87 | $7K | 22,025 |
| 2025-01-28 | Burrows Francis Chief Scientific Officer | Sale | −1,320 | $7.87 | $10K | 20,705 |
| 2025-01-02 | Burrows Francis Chief Scientific Officer | Grant or award · Option to purchase common stock | +185,000 | 185,000 |
Page 1 of 1 · 11 trades